Sporos Bioven­tures taps first CEO dur­ing pe­ri­od of 'ex­plo­sive growth'; In the wake of murky Hunter syn­drome da­ta, De­nali bulks up C-suite

Al­most five months af­ter emerg­ing from stealth mode on a mis­sion to lever­age work be­ing done in “fly­over” states like Texas and Wis­con­sin, Sporos Bioven­tures has named its first of­fi­cial CEO.

Amit Rakhit left his role as pres­i­dent and CMO of Ovid Ther­a­peu­tics to take the helm at Sporos, a Hous­ton-based up­start launched by Gen­zyme vet Michael Wyz­ga, ex-MD An­der­son chief Ron De­Pin­ho, Bridge­Bio co-founder Pe­ter Fein­berg, Tvar­di Ther­a­peu­tics CSO Jeno Gyuris, and en­tre­pre­neur Alex Cran­berg.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER